CN104383127A - Chinese medicinal composition for treating asthma - Google Patents

Chinese medicinal composition for treating asthma Download PDF

Info

Publication number
CN104383127A
CN104383127A CN201410683223.2A CN201410683223A CN104383127A CN 104383127 A CN104383127 A CN 104383127A CN 201410683223 A CN201410683223 A CN 201410683223A CN 104383127 A CN104383127 A CN 104383127A
Authority
CN
China
Prior art keywords
chinese medicinal
radix
medicinal composition
asthma
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410683223.2A
Other languages
Chinese (zh)
Inventor
周舜宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410683223.2A priority Critical patent/CN104383127A/en
Publication of CN104383127A publication Critical patent/CN104383127A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a Chinese medicinal composition for treating asthma. The Chinese medicinal composition is prepared from the following raw materials: radix codonopsis pilosulae, cassia barks, dried human placenta, Chinese eaglewood, Chinese arborvitae twigs, howthorn roots, saxifraga, baikal skullcap roots, earthworm, Indian buead, cassia twigs, largehead atractylodes rhizome, fried licorice roots, ginkgo seeds, ephedra, Chinese magnoliavine fruits and apricot kernel. The raw materials for preparing the Chinese medicinal composition are pure Chinese medicinal herbs, and the Chinese medicinal composition has a significant effect of treating asthma and can not cause any side or toxic effect.

Description

A kind of Chinese medicine composition for the treatment of asthma
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of asthma.
Background technology
Asthma is a kind of common respiratory tract disease, is known as one of four large pertinacious diseases by world medical circle, be listed in the ten large causes of death.Asthma is the chronic airway inflammation participated in by the inflammation such as eosinophilic granulocyte, mastocyte cell.Show as the panting of repeated relapsing, expiratory dyspnea, the symptom such as uncomfortable in chest.Asthma is a kind of chronic disease all had a significant effect with society to patient and family thereof.Airway inflammation is almost the common trait of all types asthma, is also the basis of clinical symptoms and airway hyperreactivity.Use hormone, Claritin and the immunomodulator etc. with antiinflammatory action, to reach antiinflammatory and to reduce for the purpose of airway reactivity, become the main method for the treatment of asthma now.Current treatment means can make the asthmatic patient disease close to 80% obtain extraordinary control, and Working Life hardly by the impact of disease, but just controls symptom, and can not reach the effect for the treatment of both the principal and secondary aspects of a disease, and there is obvious toxic-side effects and untoward reaction.
Summary of the invention
For above-mentioned the deficiencies in the prior art, the technical issues that need to address of the present invention are to provide a kind of instant effect, not easily recur, the medicine of the treatment asthma had no side effect.
The concrete technical scheme that the present invention takes is:
Treat a Chinese medicine composition for asthma, it is made up of following raw material: Radix Codonopsis, Cortex Cinnamomi, Placenta Hominis, Lignum Aquilariae Resinatum, Cacumen Platycladi, Fructus Crataegi are with, Herba Saxifragae, Radix Scutellariae, Lumbricus, Poria, Ramulus Cinnamomi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Semen Ginkgo, Herba Ephedrae, Fructus Schisandrae Chinensis, Semen Armeniacae Amarum.
Described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 6 ?10g, Cortex Cinnamomi 10 ?15g, Placenta Hominis 6 ?10g, Lignum Aquilariae Resinatum 6 ?10g, Cacumen Platycladi 10 ?12g, Fructus Crataegi with 15 ?20g, Herba Saxifragae 15 ?20g, Radix Scutellariae 6 ?10g, Lumbricus 6 ?10g, Poria 6 ?10g, Ramulus Cinnamomi 15 ?20g, the Rhizoma Atractylodis Macrocephalae 15 ?20g, Radix Glycyrrhizae Preparata 15 ?20g, Semen Ginkgo 15 ?20g, Herba Ephedrae 6 ?10g, Fructus Schisandrae Chinensis 6 ?10g, Semen Armeniacae Amarum 15 ?20g.
Preferably, described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 8g, Cortex Cinnamomi 12.5g, Placenta Hominis 8g, Lignum Aquilariae Resinatum 8g, Cacumen Platycladi 11g, Fructus Crataegi are with 17.5g, Herba Saxifragae 17.5, Radix Scutellariae 8g, Lumbricus 8g, Poria 8g, Ramulus Cinnamomi 17.5g, Rhizoma Atractylodis Macrocephalae 17.5g, Radix Glycyrrhizae Preparata 17.5g, Semen Ginkgo 17.5g, Herba Ephedrae 8g, Fructus Schisandrae Chinensis 8g, Semen Armeniacae Amarum 17.5g.
During preparation, above-mentioned raw material of Chinese medicine is put into warm water invade bubble 2 ?3 hours, add decoction twice, four hours first times, filter, then decoct with water 2 hours, filter, twice filtrate is mixed to get medicament.
Its medical material efficacy effect is respectively:
1, Radix Codonopsis: there is invigorating the spleen and replenishing QI, effect of spleen invigorating lung benefiting;
2, Cortex Cinnamomi: there is benefit fire supporing yang, let the fire back to its origin, effect of dispersing cold for relieving pain;
3, Placenta Hominis: there is the kidney invigorating and essence nourishing, effect of benefiting QI and nourishing blood;
3, Lignum Aquilariae Resinatum: there are promoting the circulation of QI to relieve pain, warming middle-JIAO to send down the adverse QI, effect of helping inspiration to relieve asthma;
4, Cacumen Platycladi: there is removing heat from blood, hemostasis, wind-damp dispelling, effect of loose toxic swelling;
5, Fructus Crataegi is followed: have effect that removing food stagnancyization is stagnant, restrain dysentery relieving, activating blood circulation to dissipate blood stasis;
6, Herba Saxifragae: the effect with cardiotonic, diuresis, anesthetic action;
7, Radix Scutellariae: there is heat clearing and damp drying, removing heat from blood is antiabortive, effect of removing toxic substances;
8, Lumbricus: have heat clearing away suppressing the hyperactive liver, relieving spasm by subduing liver-wind, relieving asthma, diuresis, dredging collateral eliminating impediment effect;
9, Poria: there is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming;
10, Ramulus Cinnamomi: there is diaphoresis expelling pathogenic factors from muscles, effect of warming the meridian and promoting blood circulation;
11, the Rhizoma Atractylodis Macrocephalae: there is enhancing immunologic function, effect of blood vessel dilating;
12, Radix Glycyrrhizae Preparata: there is spleen reinforcing stomach function regulating, effect of Yiqi and vein recovery;
13, Semen Ginkgo: there is gas of astringing the lung, relieving asthma and cough, effect that leukorrhagia stopping is turbid;
16, Herba Ephedrae: there is diaphoresis cold expelling, depressed lung-energy dispersing, effect of inducing diuresis to remove edema;
17, Fructus Schisandrae Chinensis: there is supplementing QI for promoting the production of body fluid, the kidney invigorating is nourished heart, and restrains astringent or styptic treatment for spontaneous sweating effect;
18, Semen Armeniacae Amarum: there is sending down the abnormal ascending QI relieving cough and asthma, effect of loosening bowel to relieve constipation.
The invention has the beneficial effects as follows: the present invention adopts pure raw material of Chinese medicine, have obvious effect to the treatment of asthma, and without any side effects.
Detailed description of the invention
Below preferred embodiment of the present invention is described in detail, can be easier to make advantages and features of the invention be readily appreciated by one skilled in the art, thus more explicit defining is made to protection scope of the present invention.
Embodiment 1
Treat a Chinese medicine composition for asthma, it is made up of following raw material: Radix Codonopsis, Cortex Cinnamomi, Placenta Hominis, Lignum Aquilariae Resinatum, Cacumen Platycladi, Fructus Crataegi are with, Herba Saxifragae, Radix Scutellariae, Lumbricus, Poria, Ramulus Cinnamomi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Semen Ginkgo, Herba Ephedrae, Fructus Schisandrae Chinensis, Semen Armeniacae Amarum.
Described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 6g, Cortex Cinnamomi 10g, Placenta Hominis 6g, Lignum Aquilariae Resinatum 6g, Cacumen Platycladi 10g, Fructus Crataegi are with 15g, Herba Saxifragae 15g, Radix Scutellariae 6g, Lumbricus 6g, Poria 6g, Ramulus Cinnamomi 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Glycyrrhizae Preparata 15g, Semen Ginkgo 15g, Herba Ephedrae 6g, Fructus Schisandrae Chinensis 6g, Semen Armeniacae Amarum 15g.
During preparation, above-mentioned raw material of Chinese medicine is put into warm water and invades bubble 2 hours, add decoction twice, four hours first times, filter, then decoct with water 2 hours, filter, twice filtrate is mixed to get medicament.
Embodiment 2
Treat a Chinese medicine composition for asthma, it is made up of following raw material: Radix Codonopsis, Cortex Cinnamomi, Placenta Hominis, Lignum Aquilariae Resinatum, Cacumen Platycladi, Fructus Crataegi are with, Herba Saxifragae, Radix Scutellariae, Lumbricus, Poria, Ramulus Cinnamomi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Semen Ginkgo, Herba Ephedrae, Fructus Schisandrae Chinensis, Semen Armeniacae Amarum.
Described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 8g, Cortex Cinnamomi 12.5g, Placenta Hominis 8g, Lignum Aquilariae Resinatum 8g, Cacumen Platycladi 11g, Fructus Crataegi are with 17.5g, Herba Saxifragae 17.5, Radix Scutellariae 8g, Lumbricus 8g, Poria 8g, Ramulus Cinnamomi 17.5g, Rhizoma Atractylodis Macrocephalae 17.5g, Radix Glycyrrhizae Preparata 17.5g, Semen Ginkgo 17.5g, Herba Ephedrae 8g, Fructus Schisandrae Chinensis 8g, Semen Armeniacae Amarum 17.5g.
During preparation, above-mentioned raw material of Chinese medicine is put into warm water and invades bubble 2.5 hours, add decoction twice, four hours first times, filter, then decoct with water 2 hours, filter, twice filtrate is mixed to get medicament.
Embodiment 3
Treat a Chinese medicine composition for asthma, it is made up of following raw material: Radix Codonopsis, Cortex Cinnamomi, Placenta Hominis, Lignum Aquilariae Resinatum, Cacumen Platycladi, Fructus Crataegi are with, Herba Saxifragae, Radix Scutellariae, Lumbricus, Poria, Ramulus Cinnamomi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Semen Ginkgo, Herba Ephedrae, Fructus Schisandrae Chinensis, Semen Armeniacae Amarum.
Described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 10g, Cortex Cinnamomi 15g, Placenta Hominis 10g, Lignum Aquilariae Resinatum 10g, Cacumen Platycladi 12g, Fructus Crataegi are with 20g, Herba Saxifragae 20g, Radix Scutellariae 10g, Lumbricus 10g, Poria 10g, Ramulus Cinnamomi 20g, Rhizoma Atractylodis Macrocephalae 20g, Radix Glycyrrhizae Preparata 20g, Semen Ginkgo 20g, Herba Ephedrae 10g, Fructus Schisandrae Chinensis 10g, Semen Armeniacae Amarum 20g.
During preparation, above-mentioned raw material of Chinese medicine is put into warm water and invades bubble 3 hours, add decoction twice, four hours first times, filter, then decoct with water 2 hours, filter, twice filtrate is mixed to get medicament.

Claims (3)

1. treat a Chinese medicine composition for asthma, it is characterized in that being made up of following raw material: Radix Codonopsis, Cortex Cinnamomi, Placenta Hominis, Lignum Aquilariae Resinatum, Cacumen Platycladi, Fructus Crataegi are with, Herba Saxifragae, Radix Scutellariae, Lumbricus, Poria, Ramulus Cinnamomi, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae Preparata, Semen Ginkgo, Herba Ephedrae, Fructus Schisandrae Chinensis, Semen Armeniacae Amarum.
2. the Chinese medicine composition for the treatment of asthma according to claim 1, is characterized in that described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 6 ?10g, Cortex Cinnamomi 10 ?15g, Placenta Hominis 6 ?10g, Lignum Aquilariae Resinatum 6 ?10g, Cacumen Platycladi 10 ?12g, Fructus Crataegi with 15 ?20g, Herba Saxifragae 15 ?20g, Radix Scutellariae 6 ?10g, Lumbricus 6 ?10g, Poria 6 ?10g, Ramulus Cinnamomi 15 ?20g, the Rhizoma Atractylodis Macrocephalae 15 ?20g, Radix Glycyrrhizae Preparata 15 ?20g, Semen Ginkgo 15 ?20g, Herba Ephedrae 6 ?10g, Fructus Schisandrae Chinensis 6 ?10g, Semen Armeniacae Amarum 15 ?20g.
3. the Chinese medicine composition for the treatment of asthma according to claim 1, is characterized in that described herbal raw material is made up of following parts by weight proportioning: Radix Codonopsis 8g, Cortex Cinnamomi 12.5g, Placenta Hominis 8g, Lignum Aquilariae Resinatum 8g, Cacumen Platycladi 11g, Fructus Crataegi are with 17.5g, Herba Saxifragae 17.5, Radix Scutellariae 8g, Lumbricus 8g, Poria 8g, Ramulus Cinnamomi 17.5g, Rhizoma Atractylodis Macrocephalae 17.5g, Radix Glycyrrhizae Preparata 17.5g, Semen Ginkgo 17.5g, Herba Ephedrae 8g, Fructus Schisandrae Chinensis 8g, Semen Armeniacae Amarum 17.5g.
CN201410683223.2A 2014-11-24 2014-11-24 Chinese medicinal composition for treating asthma Pending CN104383127A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410683223.2A CN104383127A (en) 2014-11-24 2014-11-24 Chinese medicinal composition for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410683223.2A CN104383127A (en) 2014-11-24 2014-11-24 Chinese medicinal composition for treating asthma

Publications (1)

Publication Number Publication Date
CN104383127A true CN104383127A (en) 2015-03-04

Family

ID=52601151

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410683223.2A Pending CN104383127A (en) 2014-11-24 2014-11-24 Chinese medicinal composition for treating asthma

Country Status (1)

Country Link
CN (1) CN104383127A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1386516A (en) * 2001-05-18 2002-12-25 王建立 Chinese-medicinal capsule for treating cough asthma
CN1899556A (en) * 2006-07-19 2007-01-24 罗世斌 Medicine for treating trachitis and asthma
CN103690918A (en) * 2013-12-24 2014-04-02 青岛安信医疗器械有限公司 Traditional Chinese medicine for adjuvant treatment of bronchial asthma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1386516A (en) * 2001-05-18 2002-12-25 王建立 Chinese-medicinal capsule for treating cough asthma
CN1899556A (en) * 2006-07-19 2007-01-24 罗世斌 Medicine for treating trachitis and asthma
CN103690918A (en) * 2013-12-24 2014-04-02 青岛安信医疗器械有限公司 Traditional Chinese medicine for adjuvant treatment of bronchial asthma

Similar Documents

Publication Publication Date Title
CN103479962B (en) Traditional Chinese medicine preparation for treating protrusion and hyperplasia of human cervical and lumbar vertebra
CN100577198C (en) Medicine for curing cardio-cerebrovascular disease
CN102512565B (en) Traditional Chinese medicine composition for treating lumbago due to kidney deficiency
CN103041271B (en) Traditional Chinese medicine composition for treating emphysema
CN105012571A (en) Drug for treating demyelinating polyneuropathy and preparation method of drug
CN103705900A (en) Traditional Chinese medicine composition for treating hypertension
CN102836275A (en) Medicine for treating hypertension
CN103191229B (en) Traditional Chinese medicine for treating swelling of knee joints
CN105168572A (en) Medicine for fast treating inflammatory demyelinating polyneuropathy
CN104873697A (en) Traditional Chinese medicine composition for treating gastrointestinal dampness and heat type urticaria
CN104383127A (en) Chinese medicinal composition for treating asthma
CN104548012A (en) Traditional Chinese medicine composition for treating amyloid cardiomyopathy
CN104116934A (en) Traditional Chinese medicine composition for treating lumbago caused by kidney deficiency
CN103830682A (en) Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes
CN103800833A (en) Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin
CN103784574B (en) A kind of Chinese medicine for oral administration preventing and treating hemolytic disease of newborn
CN103028063B (en) Traditional Chinese medicine composition for treating nephropathy
CN1879811B (en) Chinese medicinal composition for treating epilepsy
CN105055840A (en) Drug for treating arrhythmia and preparation method thereof
CN103028104B (en) Traditional Chinese medicine composition for treating abdominal pain
CN104784478A (en) Traditional Chinese medicine composition for treating deficiency of kidney yin and preparation method of traditional Chinese medicine composition
CN104606453A (en) Traditional Chinese medicine composition for treating lumbago due to kidney deficiency
CN105477458A (en) High blood pressure treating drug
CN104147386A (en) Traditional Chinese medicinal preparation for treating migraine and preparation method thereof
CN105288174A (en) Traditional Chinese medicine for treating ulcerative colitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150304

WD01 Invention patent application deemed withdrawn after publication